Akebia Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Akebia Therapeutics is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is €-0.07. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 56.07M	$ 42.05M	$ 42.24M	$ 40.13M	$ 55.18M
Gross Profit	$ 36.70M	$ 24.04M	$ 48.10M	$ 40.13M	$ 55.18M
EBIT	$ -4.81M	$ -12.76M	$ -9.27M	$ -15.74M	$ -15.51M
EBITDA	$ 2.40M	$ -3.37M	$ 123.00K	$ -6.35M	$ 42.26M
Net Income Common Stockholders	$ -47.00K	$ -14.49M	$ -11.17M	$ -26.22M	$ -7.55M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 42.92M	$ 46.53M	$ 53.57M	$ 57.00M	$ 90.47M
Total Assets	$ 241.70M	$ 235.00M	$ 253.67M	$ 276.86M	$ 351.83M
Total Debt	$ 43.63M	$ 52.84M	$ 53.97M	$ 77.71M	$ 95.04M
Net Debt	$ 705.00K	$ 6.31M	$ 394.00K	$ 20.71M	$ 4.57M
Total Liabilities	$ 272.29M	$ 274.42M	$ 280.52M	$ 291.21M	$ 342.49M
Stockholders Equity	$ -30.58M	$ -39.42M	$ -26.81M	$ -14.35M	$ 9.34M
Cash Flow	-
Free Cash Flow	$ -2.31M	$ -7.13M	$ 3.64M	$ -17.58M	$ -54.68M
Operating Cash Flow	$ -2.31M	$ -7.13M	$ 3.64M	$ -17.58M	$ -54.68M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ -1.29M	$ 50.00K	$ -8.00M	$ -15.97M	$ -1.00K

Currency in USD

Akebia Therapeutics Earnings and Revenue History

Income Statement >

Akebia Therapeutics Debt to Assets

Balance Sheet >

Akebia Therapeutics Cash Flow

Cash Flow >

Akebia Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing